The Effect of Enzyme-containing Mouth Spray on Oral Health Status and S.Mutans Levels in Paediatric Patients

June 10, 2024 updated by: Ashwini M. Madawana, Hospital Universiti Sains Malaysia

The Effect of Enzyme-containing Mouth Spray on Oral Health Status and S.Mutans Levels in Paediatric Patients Attending Hospital Universiti Sains Malaysia ( HUSM ) , Kelantan

An interventional study was done on evaluating the Effect of Enzyme-containing Mouth Spray on Oral Health Status and S.Mutans levels in Paediatric Patients attending Hospital Universiti Sains Malaysia ( HUSM ) , Kelantan. This study compared the gingivitis score , plaque score and saliva bacteria count between the patients receiving a standard preventive advice alongside with normal saline mouth spray and those receiving standard preventive advice alongside with an enzyme containing mouth spray .

Study Overview

Detailed Description

General Objective

To evaluate the effect of enzyme-containing mouth sprays on children's oral health compared to those receiving normal saline mouth spray with standard preventive advice after a 4-week follow-up.

Specific Objectives

  1. To compare the mean plaque score in children using enzyme-containing mouth sprays with standard preventive advice compared to children receiving normal saline mouth spray with standard preventive advice after a 4-week follow-up.
  2. To compare the mean gingivitis score in children using enzyme-containing mouth sprays with standard preventive advice compared to children receiving normal saline mouth spray with standard preventive advice after a 4-week follow-up.
  3. To compare the mean saliva bacterial count in children using enzyme-containing mouth sprays with standard preventive advice compared to children receiving receiving normal saline mouth spray with standard preventive advice after a 4-week follow-up.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kelantan
      • Kubang Kerian, Kelantan, Malaysia, 16150
        • Hospital Universiti Sains Malaysia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 months to 3 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children of age group 4-7

Exclusion Criteria:

  • Children with medical problems
  • Children with Special Needs
  • Uncooperative Children ( Level of Cooperation would be measured using Frankl's behavior scale)

Reviewer's comment : To list down Frankl's Classification and how we define uncooperative

As per AAPD 2022 , The Frankl behavior rating scale is a frequently used behavior rating systems in both clinical dentistry and research. This scale indicates observed child's behaviors into four categories (1; Definitely negative, 2; Negative, 3; Positive, 4; Definitely positive)

  1. _ _ Definitely negative. Refusal of treatment, forceful crying, fearfulness, or any other overt evidence of extreme negativism.
  2. _ Negative. Reluctance to accept treatment, uncooperative, some evidence of negative attitude but not pronounced (sullen, withdrawn).
  3. + Positive. Acceptance of treatmen, cautious behavior at times, willingness to comply with the dentist, at times with reservation, but patient follows the dentist's directions cooperatively.
  4. ++ Definitely positive. Good rapport with the dentist, interest in the dental procedures, laughter and enjoyment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Enzyme containing mouth spray + Standard Preventive Advice
Usage of Oral7 mouth spray along side with the Standard Preventive Advice

The following were the advices given face-to-face to parent and participant and a take home pamphlet was provided:

  • Ensure thorough cleaning especially at the gum line and in the areas between the teeth.
  • To not share toothbrushes.
  • To use toothpaste containing fluoride at least 1000ppm fluoride concentration.
  • To store toothbrushes apart to prevent spread of diseases through the bristles.
  • To brush teeth at least twice a day, after meals and before bed.
  • To brush for as long as two to three minutes.
  • Parents would be advised told to supervise the participant's brushing.

Frequency of using the Mouth spray would be two puffs, three times a day that is in the morning after waking up, during tea time and before sleep. A squirt is to be applied to the right/left side of the mouth on the buccal aspect and a squirt on the lingual aspect. Parents will be asked to apply the spray and to supervise children during oral hygiene procedures.

Other Names:
  • Oral7 mouth spray
Placebo Comparator: Normal Saline mouth spray +Standard Preventive Advice
Usage of normal saline containing mouth spray along side with the Standard Preventive Advice

The following were the advices given face-to-face to parent and participant and a take home pamphlet was provided:

  • Ensure thorough cleaning especially at the gum line and in the areas between the teeth.
  • To not share toothbrushes.
  • To use toothpaste containing fluoride at least 1000ppm fluoride concentration.
  • To store toothbrushes apart to prevent spread of diseases through the bristles.
  • To brush teeth at least twice a day, after meals and before bed.
  • To brush for as long as two to three minutes.
  • Parents would be advised told to supervise the participant's brushing.

Frequency of using the mouth spray would be two puffs, three times a day that is in the morning after waking up, during tea time and before sleep. A squirt is to be applied to the right/left side of the mouth on the buccal aspect and a squirt on the lingual aspect. Parents will be asked to apply the spray and to supervise children during oral hygiene procedures.

Other Names:
  • Normal Saline Mouth Spray

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plaque Score
Time Frame: 4 weeks

Was measured using the Silness-Loe Plaque Index 1964 from each patient before and after the intervention in both control and case study groups and the mean score and standard deviation was recorded in a table.

Scoring Criteria 0 No plaque

  1. A film of plaque adhering to the free gingival margin and adjacent area of the tooth.
  2. Moderate accumulation of deposits within the gingival pocket, on the gingival margin and/ or adjacent tooth surface.
  3. Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

PIaque Score formula:

Total scores / No of teeth examined

Range of scores :

Excellent : 0 Good : 0.1-0.9 Fair: 1.0-1.9 Poor: 2.0-3.0

4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gingivitis Score
Time Frame: 4 weeks

Was measured using the Loe and Silness Gingival Index 1963 from each patient before and after the intervention in both control and case study groups and the mean score and standard deviation would be recorded in a table.

Scoring Criteria 0 No inflammation.

  1. Mild inflammation, slight change in color, slight edema, no bleeding on probing.
  2. Moderate inflammation, moderate glazing, redness, bleeding on probing.
  3. Severe inflammation, marked redness and hypertrophy, ulceration, tendency to spontaneous bleeding.

Gingivitis score for the individual would be calculated using a formula as follows :

Sum of indices of teeth / no of teeth examined

These scores was then classified into either a Mild , Moderate or Severe form of Gingivitis as follows :

Mild gingivitis : 0.1-1.0 Moderate gingivitis : 1.1-2.0 Severe gingivitis : 2.1-3.0

4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Saliva Bacterial Count
Time Frame: 4 weeks
The saliva sample was collected from 3 patients each of both case control and study groups before and after the intervention. Saliva samples were collected at the start of the study that is during the delivery of the short dental hygiene educational message, and after 4 weeks. Every child involved was then told to spit in a centrifuge tube to obtain 1-2 ml of total volume. The saliva was then cultured in the lab for saliva bacteria analysis.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr Ashwini M.Madawana, BDS, Hospital Universiti Sains Malaysia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 31, 2023

Primary Completion (Actual)

January 1, 2024

Study Completion (Actual)

January 31, 2024

Study Registration Dates

First Submitted

October 3, 2022

First Submitted That Met QC Criteria

October 9, 2022

First Posted (Actual)

October 12, 2022

Study Record Updates

Last Update Posted (Actual)

June 11, 2024

Last Update Submitted That Met QC Criteria

June 10, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • HUSMalaysia

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual Participant data would be protected under the Ethical Board of Hospital University Sains Malaysia .

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe